| Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis FM Brennan, A Jackson, D Chantry, R Maini, M Feldmann The Lancet 334 (8657), 244-247, 1989 | 1333 | 1989 |
| BCG immunotherapy of bladder cancer: 20 years on AB Alexandroff, AM Jackson, MA O'Donnell, K James The Lancet 353 (9165), 1689-1694, 1999 | 593 | 1999 |
| IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines XW Zhu, LA Mulcahy, RAA Mohammed, AHS Lee, HA Franks, L Kilpatrick, ... Breast Cancer Research 10, 1-11, 2008 | 308 | 2008 |
| Changes in urinary cytokines and soluble intercellular adhesion molecule‐1 (ICAM‐1) in bladder cancer patients after Bacillus Calmette—Guérin (BCG) immunotherapy AM Jackson, AB Alexandroff, RW Kelly, A Skibinska, K Esuvaranathan, ... Clinical & Experimental Immunology 99 (3), 369-375, 1995 | 206 | 1995 |
| Cytokine production in culture by cells isolated from the synovial membrane FM Brennan, D Chantry, AM Jackson, RN Mainif, M Feldmann T–Cell Activation in Health and Disease, 177-186, 1989 | 188 | 1989 |
| Mechanisms of action of intravesical bacille Calmette-Guerin: local immune mechanisms S Prescott, AM Jackson, SJ Hawkyard, AB Alexandroff, K James Clinical infectious diseases 31 (Supplement_3), S91-S93, 2000 | 135 | 2000 |
| Role for CD40–CD40 ligand interactions in the immune response to solid tumours AB Alexandroff, AM Jackson, T Paterson, JL Haley, JA Ross, DL Longo, ... Molecular immunology 37 (9), 515-526, 2000 | 131 | 2000 |
| Expression of Interleukin-18, a Th1 Cytokine, in Human Gastric Mucosa Is Increased in Helicobacter pylori Infection T Tomita, AM Jackson, N Hida, M Hayat, MF Dixon, T Shimoyama, ... The Journal of infectious diseases 183 (4), 620-627, 2001 | 124 | 2001 |
| T cells expressing γδ chain receptors in rheumatoid arthritis FM Brennan, M Londei, AM Jackson, T Hercend, MB Brenner, RN Maini, ... Journal of autoimmunity 1 (4), 319-326, 1988 | 115 | 1988 |
| Recent advances in bacillus Calmette–Guerin immunotherapy in bladder cancer AB Alexandroff, S Nicholson, PM Patel, AM Jackson Immunotherapy 2 (4), 551-560, 2010 | 95 | 2010 |
| Incidental findings found in “healthy” volunteers during imaging performed for research: current legal and ethical implications TC Booth, A Jackson, JM Wardlaw, SA Taylor, AD Waldman The British journal of radiology 83 (990), 456-465, 2010 | 94 | 2010 |
| Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy MR Crittenden, J Baird, D Friedman, T Savage, L Uhde, A Alice, B Cottam, ... Oncotarget 7 (48), 78653, 2016 | 90 | 2016 |
| Interleukin-6 production by bladder tumors is upregulated by BCG immunotherapy K Esuvaranathan, AB Alexandroff, M McIntyre, AM Jackson, S Prescott, ... The Journal of urology 154 (2), 572-575, 1995 | 90 | 1995 |
| A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy KJ Radford, DE Higgins, S Pasquini, EJ Cheadle, L Carta, AM Jackson, ... Gene therapy 9 (21), 1455-1463, 2002 | 87 | 2002 |
| Bugs as drugs for cancer EJ Cheadle, AM Jackson Immunology 107 (1), 10, 2002 | 75 | 2002 |
| Prognosis of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer by immunological urinary measurements: statistically weighted syndromes analysis AM Jackson, AV Ivshina, O Senko, A Kuznetsova, A Sundan, ... The Journal of urology 159 (3), 1054-1063, 1998 | 71 | 1998 |
| Cytokine‐modified Mycobacterium smegmatis as a novel anticancer immunotherapy SL Young, M Murphy, XW Zhu, P Harnden, MA O'Donnell, K James, ... International journal of cancer 112 (4), 653-660, 2004 | 69 | 2004 |
| Induction of ICAM 1 expression on bladder tumours by BCG immunotherapy. AM Jackson, AB Alexandroff, M McIntyre, K Esuvaranathan, K James, ... Journal of clinical pathology 47 (4), 309-312, 1994 | 65 | 1994 |
| Imaging and target volume delineation in glioma GA Whitfield, SR Kennedy, IK Djoukhadar, A Jackson Clinical Oncology 26 (7), 364-376, 2014 | 60 | 2014 |
| Resistance mechanisms and barriers to successful immunotherapy for treating glioblastoma J Adhikaree, J Moreno-Vicente, AP Kaur, AM Jackson, PM Patel Cells 9 (2), 263, 2020 | 58 | 2020 |
Michael GoughEarle A. Chiles Research Institute, Providence Cancer Center, Portland OR在 providence.org 的电子邮件经过验证
